Search results for "From ACP Internist"
Annual FIT has moderate to high sensitivity and specificity for screening asymptomatic adults
Fecal immunochemical tests (FITs) are noninvasive, easy to prepare, and inexpensive and are as effective as colonoscopy when used in a consistent fashion to screen for colorectal cancer, an editorial stated.
https://gastroenterology.acponline.org/archives/2019/03/22/9.htm
22 Mar 2019
Time of day associated with ordering, completion of cancer screening
An editorial noted that referrals to screening could be handled by other clinic staff, easing the burden on physicians.
https://gastroenterology.acponline.org/archives/2019/05/24/7.htm
24 May 2019
Rethinking SIBO in the microbiome era
The May ACP Internist includes a cover story on small intestinal bacterial overgrowth (SIBO).
https://gastroenterology.acponline.org/archives/2019/05/24/6.htm
24 May 2019
Financial incentives associated with increased FIT uptake but not increased CRC screening overall
A three-arm trial of incentives for fecal immunochemical testing (FIT) and colorectal cancer screening (CRC) tested mail-only, mail and monetary, and mail and lottery interventions.
https://gastroenterology.acponline.org/archives/2019/07/26/7.htm
26 Jul 2019
Lipophilic statins associated with significantly reduced hepatocellular carcinoma incidence, mortality in hepatitis
Potential benefits of lipophilic statins appeared to be dose- and duration-dependent, with the greatest reduction in hepatocellular carcinoma risk seen with use of a moderate-dose statin for about two years, according to data from a registry of Swedish patients with hepatitis B or C.
https://gastroenterology.acponline.org/archives/2019/08/23/7.htm
23 Aug 2019
Model supports high-intensity surveillance after detection of colorectal adenomas
The target population was U.S. patients ages 50, 60, or 70 years with low-risk or high-risk adenomas removed after screening via colonoscopy or fecal immunochemical testing.
https://gastroenterology.acponline.org/archives/2019/09/27/10.htm
27 Sep 2019
ACP issues new guidance on colorectal cancer screening
For asymptomatic, average-risk patients ages 50 to 75 years, the guidance suggests use of a fecal immunochemical test (FIT) or high-sensitivity guaiac-based fecal occult blood test every two years, colonoscopy every 10 years, or flexible sigmoidoscopy every 10 years plus FIT every two years.
https://gastroenterology.acponline.org/archives/2019/11/22/8.htm
22 Nov 2019
AGA releases guidelines on managing gastric intestinal metaplasia found during routine endoscopy
The guidelines from the American Gastroenterological Association (AGA) will aid clinicians' decision making for patients undergoing upper endoscopy in North America, the authors said.
https://gastroenterology.acponline.org/archives/2019/12/27/7.htm
27 Dec 2019
USPSTF expands hepatitis C screening recommendation to most adults
All adults ages 18 to 79 years should now be screened at least once, but people who use injection drugs and pregnant women may require screening more often.
https://gastroenterology.acponline.org/archives/2020/03/27/6.htm
27 Mar 2020
Middle-age adults getting less colorectal cancer screening than retirement-age adults
Specific population-based efforts to increase colorectal cancer screening are needed so that patients start at age 50 years and continue through age 75 years for the most benefit, study authors said.
https://gastroenterology.acponline.org/archives/2020/03/27/7.htm
27 Mar 2020